SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-011948
Filing Date
2019-08-09
Accepted
2019-08-09 06:26:12
Documents
44
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 323026
2 ex31-1.htm EX-31.1 12744
3 ex31-2.htm EX-31.2 12767
4 ex32-1.htm EX-32.1 6713
5 ex32-2.htm EX-32.2 6862
  Complete submission text file 0001493152-19-011948.txt   2620367

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE capd-20190630.xml EX-101.INS 395132
7 XBRL SCHEMA FILE capd-20190630.xsd EX-101.SCH 27942
8 XBRL CALCULATION FILE capd-20190630_cal.xml EX-101.CAL 33540
9 XBRL DEFINITION FILE capd-20190630_def.xml EX-101.DEF 100815
10 XBRL LABEL FILE capd-20190630_lab.xml EX-101.LAB 199167
11 XBRL PRESENTATION FILE capd-20190630_pre.xml EX-101.PRE 156526
Mailing Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916
Business Address 20 RAOUL WALLENBERG ST., TEL AVIV, L3 6971916 972-3-6130421
CANNAPOWDER, INC. (Filer) CIK: 0001086082 (see all company filings)

IRS No.: 870626333 | State of Incorp.: UT | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26027 | Film No.: 191011246
SIC: 2834 Pharmaceutical Preparations